Okadaic acid induces transcription of junB through a CCAAT box and NF-Y.
The shellfish toxin, okadaic acid (OA), is a potent tumor promoter that induces expression of the proto-oncogene junB in mouse keratinocyte 308 cells. Here we show, through deletion analysis of the junB promoter, that sequences near the TATA box conferred transcriptional induction by OA. Transient transfections of luciferase constructs bearing the junB promoter with single mutations in various cis elements demonstrated that a promoter containing a mutated CCAAT box could not be induced by OA. When this CCAAT box was inserted into a heterologous promoter construct, OA induction was dependent on an intact CCAAT box. Flanking cis elements located near the CCAAT box, although not required for OA inducibility, did play a role in the basal level of transcription. NF-Y was shown by EMSA to bind to the CCAAT box. OA induction from the junB CCAAT box was blocked by dominant negative NF-YA as well as the CCAAT box-dependent anticancer drug, ET-473. Expression of a lexA/NF-YA chimeric protein demonstrated that OA induction was dependent on the binding of NF-Y family members. These studies demonstrate that OA can mediate transcriptional activation of junB through the classical CCAAT box and that transcription factor NF-Y plays a functional role in the induction.
Finch
J S
JS
Arizona Cancer Center, University of Arizona, 1515 N. Campbell Avenue, Tucson, AZ 85724-5024, USA.
Rosenberger
S F
SF
Martinez
J D
JD
Bowden
G T
GT
D000818:Animals; D001426:Bacterial Proteins / Q000378:metabolism; D001483:Base Sequence; D001665:Binding Sites / Q000187:drug effects / Q000235:genetics; D023081:CCAAT-Binding Factor / Q000378:metabolism; D002460:Cell Line; D004247:DNA / Q000187:drug effects / Q000235:genetics; D004149:Dioxoles / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D007546:Isoquinolines / Q000494:pharmacology; D008156:Luciferases / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D016254:Mutagenesis, Insertional; D009154:Mutation; D019319:Okadaic Acid / Q000494:pharmacology*; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding; D016755:Proto-Oncogene Proteins c-jun / Q000235:genetics* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin; D014158:Transcription, Genetic / Q000187:drug effects*; D000099160:LexA Repressor Protein
D001426:Bacterial Proteins; D023081:CCAAT-Binding Factor; D004247:DNA; D004149:Dioxoles; D007546:Isoquinolines; D008156:Luciferases; D019319:Okadaic Acid; D016755:Proto-Oncogene Proteins c-jun; D011993:Recombinant Fusion Proteins; D012697:Serine Endopeptidases; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin; D000099160:LexA Repressor Protein